Addressing an HIV cure in LMIC SD Ismail, J Pankrac, E Ndashimye, JL Prodger, MR Abrahams, ... Retrovirology 18 (1), 21, 2021 | 35 | 2021 |
Eradication of HIV-1 latent reservoirs through therapeutic vaccination J Pankrac, K Klein, JFS Mann AIDS research and therapy 14, 1-4, 2017 | 28 | 2017 |
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system J Pankrac, K Klein, PF McKay, DFL King, K Bain, J Knapp, T Biru, ... npj Vaccines 3 (1), 2, 2018 | 22 | 2018 |
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection JFS Mann, J Pankrac, K Klein, PF McKay, DFL King, R Gibson, ... EBioMedicine 59, 2020 | 12 | 2020 |
Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope AN Ratcliff, CM Venner, AS Olabode, J Knapp, J Pankrac, I Derecichei, ... Journal of Virology 96 (14), e01851-21, 2022 | 2 | 2022 |
Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity JFS Mann, PF McKay, K Klein, J Pankrac, JS Tregoning, RJ Shattock Immunology 165 (3), 301-311, 2022 | 1 | 2022 |
Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection MH Ngo, J Pankrac, RCY Ho, E Ndashimye, R Pawa, R Ceccacci, T Biru, ... Emerging Microbes & Infections 13 (1), 2327371, 2024 | | 2024 |
PP 3.15–00207 A polyvalent HIV-1 virus-like particle formulation drives the majority of the infectious HIV-1 reservoir out of latency within CD4+ T cells of individuals … E Arts, J Pankrac, R Ho, MH Ngo, J Prodger, A Redd, T Quinn, C Kovacs, ... | | 2022 |
Development and Evaluation of a Heterogenous Virus-Like Particle (VLP) Formulation to Achieve HIV-1 Latency Reversal and Cure JP Pankrac The University of Western Ontario (Canada), 2020 | | 2020 |
Development of a Latency Reversing Activator Vaccine (ACT-VEC) Platform as a Curative Approach for SIV J Mann, R Veazey, J Pankrac, K Klein, E Arts AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 402-402, 2016 | | 2016 |